Cyanobacteria derived compounds: Emerging drugs for cancer management.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of basic microbiology"
DOI: 10.1002/jobm.202100459
Abstract: The wide diversity of cyanobacterial species and their role in a variety of biological activities have been reported in the previous few years. Cyanobacteria, especially from marine sources, constitutes a major source of biologically active… read more here.
Keywords: emerging drugs; cyanobacteria derived; compounds emerging; derived compounds ... See more keywords
Development and Advances of Drugs for Cancer Theranostics - PART-III.
Sign Up to like & getrecommendations! Published in 2021 at "Current topics in medicinal chemistry"
DOI: 10.2174/156802662105210216122217
Abstract: read more here.
Keywords: part iii; development advances; theranostics part; drugs cancer ... See more keywords
Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
Sign Up to like & getrecommendations! Published in 2017 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2017.00273
Abstract: The repositioning or “repurposing” of existing therapies for alternative disease indications is an attractive approach that can save significant investments of time and money during drug development. For cancer indications, the primary goal of repurposed… read more here.
Keywords: giving drugs; drug; drugs second; drugs cancer ... See more keywords
Real Impact of Novel Immunotherapy Drugs in Cancer. The Experience of 10 Last Years
Sign Up to like & getrecommendations! Published in 2021 at "Toxins"
DOI: 10.3390/toxins13020149
Abstract: Intense research on immunotherapy has been conducted during recent years. As advances in the field have started changing the landscape of cancer therapy, it is necessary to assess the impact of immunotherapeutic modalities in the… read more here.
Keywords: research; immunotherapy; real impact; drugs cancer ... See more keywords